Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Mosunetuzumab for CLL MRD Clearance [Phase 1, Phase 2]
Clinical trial update for mosunetuzumab in chronic lymphocytic leukemia focusing on measurable residual disease clearance in Phase 1/2 studi…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus–associated lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma [Phase 1]
An ongoing Phase 1 clinical trial update for AS-1763 in adults with previously treated B-cell malignancies, including chronic lymphocytic le…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL [Phase 2]
Phase 2 trial evaluating MB-CART19.1, a CD19-directed CAR-T cell therapy, in relapsed or refractory CD19-positive non-Hodgkin lymphoma; curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
A clinical trial update on the FIL_SAR-CAR project evaluating sarcopenia and simplified geriatric assessment in Non-Hodgkin lymphoma patient…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
An ongoing clinical trial investigating muscle dysfunction in patients with hematologic diseases referred for stem cell transplantation.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy [Phase 2]
Phase II trial evaluating pembrolizumab plus low-dose radiotherapy for relapsed/refractory non-Hodgkin lymphoma; the study is listed as acti…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
A prospective registry study collecting diagnosis, treatment, and outcome data for adults with acute lymphoblastic leukemia and related dise…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma [Phase 3]
A Phase 3 study comparing EAP versus disease-specific chemotherapy regimens for hematopoietic stem cell mobilization in patients with Non-Ho…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients [Phase 1]
This is a Phase I study evaluating conditioning with bendamustine and melphalan followed by autologous stem cell transplantation for elderly…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This ClinicalTrials.gov entry describes a recruiting USC-led study evaluating social health, activity behaviors, and quality of life among y…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Mozobil for Autologous Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update for Mozobil (plerixafor) in autologous hematopoietic stem cell transplantation, enrolling patients with multip…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) [Phase 1]
A Phase 1 clinical trial evaluating SC262 in patients with relapsed/refractory Non-Hodgkin's lymphoma, including Large B-cell lymphoma; curr…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma [Phase 1]
This clinical trial update describes a Phase 1 study of pevonedistat in combination with ibrutinib for relapsed or refractory chronic lympho…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma [Phase 1]
This Phase 1 trial examines the safety and preliminary efficacy of BRL-201 in relapsed/refractory B-cell non-Hodgkin lymphoma and is current…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Universal CAR-T Cell Therapy for NHL [NA]
Recruitment is ongoing for a universal CAR-T cell therapy being studied in non-Hodgkin lymphoma (B-cell subtype), sponsored by Bioray Labora…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) [Phase 1]
Phase 1 trial update of CAR T cells (CARPASCIO) targeting CD19 in relapsed CD19+ malignancies after allogeneic HSCT. The study is currently …
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Emapalumab Prevention of CAR-T Cell Associated Toxicities [Phase 2]
A Phase 2 clinical trial update evaluating emapalumab for preventing CAR-T cell–related toxicities in patients with relapsed or refractory B…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CTX112 in relapsed or refractory B-cell malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas [Phase 1]
A Phase 1 study evaluating JV-213, an autologous CD79b-targeting CAR T-cell therapy, in adults with relapsed or refractory B-cell lymphomas;…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: huCART19-IL18 in CD19+ Cancers [Phase 1]
Phase 1 clinical trial of huCART19-IL18 for CD19+ cancers is currently ACTIVE_NOT_RECRUITING, sponsored by the University of Pennsylvania, i…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Long-term Follow-up Study of Patients Receiving CAR-T Cells
This clinical trial update outlines a long-term follow-up study of patients who received CAR-T cell therapy. Sponsored by the Medical Colleg…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Personalized NK Cell Therapy in CBT [Phase 2]
A Phase 2 trial from MD Anderson is evaluating personalized NK cell therapy across several hematologic cancers. The study is currently recru…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) [Phase 1]
Phase 1 clinical trial evaluating the combination of Rituximab and Tafasitamab with allogeneic NK cells in relapsed/refractory B-cell non-Ho…